Related references
Note: Only part of the references are listed.Histologic type predicts disparate outcomes in pediatric hepatocellular neoplasms: A Pediatric Surgical Oncology Research Collaborative study
Scott S. Short et al.
CANCER (2022)
ß-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in Cholangiocarcinoma
Yi Zhang et al.
GASTROENTEROLOGY (2022)
Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults
Pavel Sumazin et al.
JOURNAL OF HEPATOLOGY (2022)
Safety, tolerability, and anti-fibrotic efficacy of the CBP/I3-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study
Kiminori Kimura et al.
EBIOMEDICINE (2022)
Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents
Federico Selvaggi et al.
CANCERS (2022)
β-catenin cancer-enhancing genomic regions axis is involved in the development of fibrolamellar hepatocellular carcinoma
Ruhi Gulati et al.
HEPATOLOGY COMMUNICATIONS (2022)
β-Catenin Activation in Hepatocellular Cancer: Implications in Biology and Therapy
Yekaterina Krutsenko et al.
CANCERS (2021)
Olaparib Inhibits Tumor Growth of Hepatoblastoma in Patient-Derived Xenograft Models
Michael Edward Johnston et al.
HEPATOLOGY (2021)
HDAC1-Dependent Repression of Markers of Hepatocytes and P21 Is Involved in Development of Pediatric Liver Cancer
Maria Rivas et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)
Hepatoblastoma and Pediatric Hepatocellular Carcinoma: An Update
Sarangarajan Ranganathan et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2020)
Diagnostic value of serum glypican-3 alone and in combination with AFP as an aid in the diagnosis of liver cancer
Shuxia Liu et al.
CLINICAL BIOCHEMISTRY (2020)
AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway
Tianke Chen et al.
CELL DEATH & DISEASE (2020)
Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation
Katherine Haines et al.
PEDIATRIC BLOOD & CANCER (2019)
β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice
Weiqi Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Loss of hepatocyte β-catenin protects mice from experimental porphyria-associated liver injury
Harvinder Saggi et al.
JOURNAL OF HEPATOLOGY (2019)
β-Catenin and Yes-Associated Protein 1 Cooperate in Hepatoblastoma Pathogenesis
Qian Min et al.
AMERICAN JOURNAL OF PATHOLOGY (2019)
PARP1 activation increases expression of modified tumor suppressors and pathways underlying development of aggressive hepatoblastoma
Leila Valanejad et al.
COMMUNICATIONS BIOLOGY (2018)
Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial
Kiminori Kimura et al.
EBIOMEDICINE (2017)
Glypican 3 as a Serum Marker for Hepatoblastoma
Shengmei Zhou et al.
SCIENTIFIC REPORTS (2017)
FXR-Gankyrin axis is involved in development of pediatric liver cancer
Leila Valanejad et al.
CARCINOGENESIS (2017)
The genomic landscape of hepatoblastoma and their progenies with HCC-like features
Melanie Eichenmüller et al.
JOURNAL OF HEPATOLOGY (2014)
Identification of β-catenin binding regions in colon cancer cells using ChIP-Seq
Daniel Bottomly et al.
NUCLEIC ACIDS RESEARCH (2010)
Beta-Catenin Activation Promotes Liver Regeneration after Acetaminophen-Induced Injury
Udayan Apte et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer
Stefano Cairo et al.
CANCER CELL (2008)
Overexpression of regenerating islet-derived 1 alpha and 3 alpha genes in human primaryliver tumors with beta-catenin mutations
C Cavard et al.
ONCOGENE (2006)
Share Paper
